Eastern 0 7 0 7 B-clinical_variable
Cooperative 8 19 8 19 I-clinical_variable
Oncology 20 28 20 28 I-clinical_variable
Group 29 34 29 34 I-clinical_variable
( 35 36 35 36 I-clinical_variable
ECOG 36 40 36 40 I-clinical_variable
) 40 41 40 41 I-clinical_variable
performance 42 53 42 53 I-clinical_variable
status 54 60 54 60 I-clinical_variable
0 61 62 61 62 B-lower_bound
- 62 63 62 63 O
2 63 64 63 64 B-upper_bound

Has 0 3 65 68 O
at 4 6 69 71 O
least 7 12 72 77 O
one 13 16 78 81 B-lower_bound
extracranial 17 29 82 94 O
tumor 30 35 95 100 B-cancer
safely 36 42 101 107 O
treatable 43 52 108 117 O
with 53 57 118 122 O
radical 58 65 123 130 O
- 65 66 130 131 O
dose 66 70 131 135 O
radiation 71 80 136 145 B-treatment
therapy 81 88 146 153 I-treatment

Has 0 3 154 157 O
been 4 8 158 162 O
receiving 9 18 163 172 O
anti 19 23 173 177 B-treatment
- 23 24 177 178 I-treatment
PD-1 24 28 178 182 I-treatment
or 29 31 183 185 O
anti 32 36 186 190 B-treatment
- 36 37 190 191 I-treatment
PD 37 39 191 193 I-treatment
- 39 40 193 194 I-treatment
L1 40 42 194 196 I-treatment
immunotherapy 43 56 197 210 I-treatment
for 57 60 211 214 O
at 61 63 215 217 O
least 64 69 218 223 O
four 70 74 224 228 B-lower_bound
weeks 75 80 229 234 I-lower_bound

Has 0 3 235 238 O
had 4 7 239 242 O
restaging 8 17 243 252 O
imaging 18 25 253 260 O
after 26 31 261 266 O
initiation 32 42 267 277 O
of 43 45 278 280 O
immunotherapy 46 59 281 294 B-treatment
, 59 60 294 295 O
at 61 63 296 298 O
least 64 69 299 304 O
4 70 71 305 306 O
weeks 72 77 307 312 O
after 78 83 313 318 O
pre 84 87 319 322 B-treatment
- 87 88 322 323 I-treatment
immunotherapy 88 101 323 336 I-treatment
baseline 102 110 337 345 O
imaging 111 118 346 353 O
; 118 119 353 354 O
computed 120 128 355 363 B-treatment
tomography 129 139 364 374 I-treatment
( 140 141 375 376 I-treatment
CT 141 143 376 378 I-treatment
) 143 144 378 379 I-treatment
or 145 147 380 382 O
positron 148 156 383 391 B-treatment
emission 157 165 392 400 I-treatment
tomography 166 176 401 411 I-treatment
( 177 178 412 413 I-treatment
PET)/CT 178 185 413 420 I-treatment
of 186 188 421 423 O
at 189 191 424 426 O
least 192 197 427 432 O
chest 198 203 433 438 O
/ 203 204 438 439 O
upper 204 209 439 444 O
abdomen 210 217 445 452 O
must 218 222 453 457 O
be 223 225 458 460 O
performed 226 235 461 470 O
within 236 242 471 477 O
4 243 244 478 479 B-upper_bound
weeks 245 250 480 485 I-upper_bound
prior 251 256 486 491 I-upper_bound
to 257 259 492 494 O
registration 260 272 495 507 O
; 272 273 507 508 O
for 274 277 509 512 O
patients 278 286 513 521 O
with 287 291 522 526 O
history 292 299 527 534 O
of 300 302 535 537 O
brain 303 308 538 543 B-cancer
metastases 309 319 544 554 I-cancer
, 319 320 554 555 O
brain 321 326 556 561 B-treatment
magnetic 327 335 562 570 I-treatment
resonance 336 345 571 580 I-treatment
imaging 346 353 581 588 I-treatment
( 354 355 589 590 I-treatment
MRI 355 358 590 593 I-treatment
) 358 359 593 594 I-treatment
or 360 362 595 597 O
CT 363 365 598 600 O
is 366 368 601 603 O
required 369 377 604 612 O
within 378 384 613 619 O
4 385 386 620 621 O
weeks 387 392 622 627 O
of 393 395 628 630 O
registration 396 408 631 643 O
; 408 409 643 644 O
for 410 413 645 648 O
other 414 419 649 654 O
patients 420 428 655 663 O
brain 429 434 664 669 O
MRI 435 438 670 673 O
or 439 441 674 676 O
CT 442 444 677 679 O
is 445 447 680 682 O
required 448 456 683 691 O
within 457 463 692 698 O
12 464 466 699 701 B-upper_bound
weeks 467 472 702 707 I-upper_bound
of 473 475 708 710 O
registration 476 488 711 723 O

Is 0 2 724 726 O
expected 3 11 727 735 O
by 12 14 736 738 O
the 15 18 739 742 O
treating 19 27 743 751 O
medical 28 35 752 759 O
oncologist 36 46 760 770 O
to 47 49 771 773 O
continue 50 58 774 782 O
on 59 61 783 785 O
immunotherapy 62 75 786 799 B-treatment
for 76 79 800 803 O
at 80 82 804 806 O
least 83 88 807 812 O
three 89 94 813 818 B-lower_bound
more 95 99 819 823 I-lower_bound
months 100 106 824 830 I-lower_bound
; 106 107 830 831 O
imaging 108 115 832 839 O
must 116 120 840 844 O
show 121 125 845 849 O
response 126 134 850 858 O
, 134 135 858 859 O
stable 136 142 860 866 O
disease 143 150 867 874 O
, 150 151 874 875 O
or 152 154 876 878 O
modest 155 161 879 885 O
progression 162 173 886 897 O
as 174 176 898 900 O
determined 177 187 901 911 O
by 188 190 912 914 O
the 191 194 915 918 O
treating 195 203 919 927 O
medical 204 211 928 935 O
oncologist 212 222 936 946 O
; 222 223 946 947 O
if 224 226 948 950 O
there 227 232 951 956 O
is 233 235 957 959 O
modest 236 242 960 966 O
progression 243 254 967 978 O
, 254 255 978 979 O
the 256 259 980 983 O
patient 260 267 984 991 O
must 268 272 992 996 O
be 273 275 997 999 O
clinically 276 286 1000 1010 O
stable 287 293 1011 1017 O
in 294 296 1018 1020 O
terms 297 302 1021 1026 O
of 303 305 1027 1029 O
performance 306 317 1030 1041 O
status 318 324 1042 1048 O
and 325 328 1049 1052 O
overall 329 336 1053 1060 O
disease 337 344 1061 1068 O
- 344 345 1068 1069 O
related 345 352 1069 1076 O
symptoms 353 361 1077 1085 O

Pregnancy 0 9 1086 1095 B-pregnancy

women 0 5 1096 1101 B-gender
of 6 8 1102 1104 O
childbearing 9 21 1105 1117 O
potential 22 31 1118 1127 O
not 32 35 1128 1131 B-contraception_consent
willing 36 43 1132 1139 I-contraception_consent
/ 43 44 1139 1140 I-contraception_consent
able 44 48 1140 1144 I-contraception_consent
to 49 51 1145 1147 I-contraception_consent
use 52 55 1148 1151 I-contraception_consent
contraception 56 69 1152 1165 I-contraception_consent
during 70 76 1166 1172 O
protocol 77 85 1173 1181 O
treatment 86 95 1182 1191 O

